During the past decade, Oklahoma Medical Research Foundation conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 27 clinical trials were completed, i.e. on average, 79.4% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 16 clinical trials were completed. i.e. 94.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oklahoma Medical Research Foundation" #1 sponsor was "SWOG Cancer Research Network" with 38 trials, followed by "Oklahoma Medical Research Foundation" with 10 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 7 trials sponsored, "Pfizer" with 6 trials sponsored and "Eli Lilly and Company" with 6 trials sponsored. Other sponsors include 46 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oklahoma Medical Research Foundation" #1 collaborator was "National Cancer Institute (NCI)" with 48 trials as a collaborator, "SWOG Cancer Research Network" with 8 trials as a collaborator, "Eastern Cooperative Oncology Group" with 5 trials as a collaborator, "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" with 5 trials as a collaborator and "Autoimmunity Centers of Excellence" with 4 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Oklahoma Medical Research Foundation" are "Systemic Lupus Erythematosus" (25 trials), "Lupus Erythematosus, Systemic" (11 trials), "Rheumatoid Arthritis" (11 trials), "Lung Cancer" (10 trials) and "Multiple Sclerosis" (8 trials). Many other conditions were trialed in "Oklahoma Medical Research Foundation" in a lesser frequency.

Most popular intervention types in "Oklahoma Medical Research Foundation" are "Drug" (97 trials), "Biological" (20 trials), "Other" (12 trials), "Radiation" (12 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "cisplatin" (10 trials), "radiation therapy" (9 trials), "cyclophosphamide" (8 trials) and "etoposide" (8 trials). Other intervention names were less common.

The vast majority of trials in "Oklahoma Medical Research Foundation" are 106 trials for "All" genders and 11 trials for "Female" genders.

Currently, there are NaN active trials in "Oklahoma Medical Research Foundation". 1 are not yet recruiting, 11 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 75 completed trials in Oklahoma Medical Research Foundation, undefined suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Oklahoma Medical Research Foundation, 9 "Phase 1" clinical trials were conducted, 57 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 3 trials that are defined as “Not Applicable".

Oklahoma Medical Research Foundation has several departments that took part in Clinical trials: "Oklahoma Medical Research Foundation: Arthritis and Clinical Immunology Research Program" - 3 trials